If we look at it on an annual basis the benefit that a Medicare beneficiary would get, for instance, in Nebraska or Iowa or Oregon, it would be in this range, below $4,000 on an annual basis. In some parts of the country it is $6,000. The average is about $4,500. But look at what happens over time as you go out to the year 2002. If nothing changes in Medicare, you can see that the difference between these two increases over time. Let me just show you how this affects my particular State. The dark blue areas are counties that are more than 30 percent below the national average. Light blue is 20 to 30 percent. I practiced medicine for a while in the State of Oregon. Oregon has been very efficient in their health care. Look at the State of Oregon, for example; the whole western part of the State is reimbursed at levels 30 percent or more less than the average. Our plan addresses this inequity because it immediately bumps up the baseline, the minimum amount that any county could receive.
Greg Ganske: “If we look at it on an annual basis the benefit that a Medicare beneficiary would get, for instance, in Nebraska or Iowa…”
Editor's note · Context
Discussing Medicare reimbursement rates and inequities in funding across states.
Share
More from Greg Ganske
I commend the objectives of the Grassley amendment in the Senate and I believe we should encourage Members of the House serving on the farm bill conference to accept the language as it was adopted in the Senate version. The Grassley…
Mr. Chairman, these are the contracted security screeners that we will be voting for if we vote for the Young bill. They will be hired by those private contractors. Let me read this from a woman I respect very much, a strong conservative…
this is a $350 billion bill. Since when has $350 billion been pencil dust, I ask my colleagues. That is a third of a trillion dollars. Mr. Speaker, 37 percent of Iowan senior citizens will have no copayment, deductible, or premium. They…
I believe there are ethical considerations that enter to the creation of an embryo for research purposes, and that is why I will support the Weldon bill. And I will vote against the Greenwood substitute.





